Hepatocellular Carcinoma Targeted Drug Market, Global Outlook and Forecast 2022-2028

Code: RW00014822357
Market Monitor Global
Aug-2022
Life Sciences
63 Pages

The most effective targeted drug introduced for HCC has been?sorafenib. Sorafenib, a multi-tyrosine kinase inhibitor (TKI), remains the only systemic targeted tumor therapy in use for advanced HCC (18-21).
This report contains market size and forecasts of Hepatocellular Carcinoma Targeted Drug in Global, including the following market information:
Global Hepatocellular Carcinoma Targeted Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Hepatocellular Carcinoma Targeted Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Sorafenib Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hepatocellular Carcinoma Targeted Drug include Bayer, Eisai, Zelgen, Cipla, Natco Pharma, BEACON Pharma, Jiangxi Shanxiang, Yao Pharma and CSPC, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Publisher has surveyed the Hepatocellular Carcinoma Targeted Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hepatocellular Carcinoma Targeted Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Hepatocellular Carcinoma Targeted Drug Market Segment Percentages, by Type, 2021 (%)
Sorafenib
Lenvatinib
Regorafenib
Other
Global Hepatocellular Carcinoma Targeted Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Hepatocellular Carcinoma Targeted Drug Market Segment Percentages, by Application, 2021 (%)
Hospital
Retail Pharmacy
Other
Global Hepatocellular Carcinoma Targeted Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Hepatocellular Carcinoma Targeted Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hepatocellular Carcinoma Targeted Drug revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Hepatocellular Carcinoma Targeted Drug revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer
Eisai
Zelgen
Cipla
Natco Pharma
BEACON Pharma
Jiangxi Shanxiang
Yao Pharma
CSPC
CHIATAI Tianqing
Simcere

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Hepatocellular Carcinoma Targeted Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hepatocellular Carcinoma Targeted Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hepatocellular Carcinoma Targeted Drug Overall Market Size
2.1 Global Hepatocellular Carcinoma Targeted Drug Market Size: 2021 VS 2028
2.2 Global Hepatocellular Carcinoma Targeted Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hepatocellular Carcinoma Targeted Drug Players in Global Market
3.2 Top Global Hepatocellular Carcinoma Targeted Drug Companies Ranked by Revenue
3.3 Global Hepatocellular Carcinoma Targeted Drug Revenue by Companies
3.4 Top 3 and Top 5 Hepatocellular Carcinoma Targeted Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Hepatocellular Carcinoma Targeted Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hepatocellular Carcinoma Targeted Drug Players in Global Market
3.6.1 List of Global Tier 1 Hepatocellular Carcinoma Targeted Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Hepatocellular Carcinoma Targeted Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Hepatocellular Carcinoma Targeted Drug Market Size Markets, 2021 & 2028
4.1.2 Sorafenib
4.1.3 Lenvatinib
4.1.4 Regorafenib
4.1.5 Other
4.2 By Type - Global Hepatocellular Carcinoma Targeted Drug Revenue & Forecasts
4.2.1 By Type - Global Hepatocellular Carcinoma Targeted Drug Revenue, 2017-2022
4.2.2 By Type - Global Hepatocellular Carcinoma Targeted Drug Revenue, 2023-2028
4.2.3 By Type - Global Hepatocellular Carcinoma Targeted Drug Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hepatocellular Carcinoma Targeted Drug Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.1.4 Other
5.2 By Application - Global Hepatocellular Carcinoma Targeted Drug Revenue & Forecasts
5.2.1 By Application - Global Hepatocellular Carcinoma Targeted Drug Revenue, 2017-2022
5.2.2 By Application - Global Hepatocellular Carcinoma Targeted Drug Revenue, 2023-2028
5.2.3 By Application - Global Hepatocellular Carcinoma Targeted Drug Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Hepatocellular Carcinoma Targeted Drug Market Size, 2021 & 2028
6.2 By Region - Global Hepatocellular Carcinoma Targeted Drug Revenue & Forecasts
6.2.1 By Region - Global Hepatocellular Carcinoma Targeted Drug Revenue, 2017-2022
6.2.2 By Region - Global Hepatocellular Carcinoma Targeted Drug Revenue, 2023-2028
6.2.3 By Region - Global Hepatocellular Carcinoma Targeted Drug Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Hepatocellular Carcinoma Targeted Drug Revenue, 2017-2028
6.3.2 US Hepatocellular Carcinoma Targeted Drug Market Size, 2017-2028
6.3.3 Canada Hepatocellular Carcinoma Targeted Drug Market Size, 2017-2028
6.3.4 Mexico Hepatocellular Carcinoma Targeted Drug Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Hepatocellular Carcinoma Targeted Drug Revenue, 2017-2028
6.4.2 Germany Hepatocellular Carcinoma Targeted Drug Market Size, 2017-2028
6.4.3 France Hepatocellular Carcinoma Targeted Drug Market Size, 2017-2028
6.4.4 U.K. Hepatocellular Carcinoma Targeted Drug Market Size, 2017-2028
6.4.5 Italy Hepatocellular Carcinoma Targeted Drug Market Size, 2017-2028
6.4.6 Russia Hepatocellular Carcinoma Targeted Drug Market Size, 2017-2028
6.4.7 Nordic Countries Hepatocellular Carcinoma Targeted Drug Market Size, 2017-2028
6.4.8 Benelux Hepatocellular Carcinoma Targeted Drug Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Hepatocellular Carcinoma Targeted Drug Revenue, 2017-2028
6.5.2 China Hepatocellular Carcinoma Targeted Drug Market Size, 2017-2028
6.5.3 Japan Hepatocellular Carcinoma Targeted Drug Market Size, 2017-2028
6.5.4 South Korea Hepatocellular Carcinoma Targeted Drug Market Size, 2017-2028
6.5.5 Southeast Asia Hepatocellular Carcinoma Targeted Drug Market Size, 2017-2028
6.5.6 India Hepatocellular Carcinoma Targeted Drug Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Hepatocellular Carcinoma Targeted Drug Revenue, 2017-2028
6.6.2 Brazil Hepatocellular Carcinoma Targeted Drug Market Size, 2017-2028
6.6.3 Argentina Hepatocellular Carcinoma Targeted Drug Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Hepatocellular Carcinoma Targeted Drug Revenue, 2017-2028
6.7.2 Turkey Hepatocellular Carcinoma Targeted Drug Market Size, 2017-2028
6.7.3 Israel Hepatocellular Carcinoma Targeted Drug Market Size, 2017-2028
6.7.4 Saudi Arabia Hepatocellular Carcinoma Targeted Drug Market Size, 2017-2028
6.7.5 UAE Hepatocellular Carcinoma Targeted Drug Market Size, 2017-2028
7 Players Profiles
7.1 Bayer
7.1.1 Bayer Corporate Summary
7.1.2 Bayer Business Overview
7.1.3 Bayer Hepatocellular Carcinoma Targeted Drug Major Product Offerings
7.1.4 Bayer Hepatocellular Carcinoma Targeted Drug Revenue in Global Market (2017-2022)
7.1.5 Bayer Key News
7.2 Eisai
7.2.1 Eisai Corporate Summary
7.2.2 Eisai Business Overview
7.2.3 Eisai Hepatocellular Carcinoma Targeted Drug Major Product Offerings
7.2.4 Eisai Hepatocellular Carcinoma Targeted Drug Revenue in Global Market (2017-2022)
7.2.5 Eisai Key News
7.3 Zelgen
7.3.1 Zelgen Corporate Summary
7.3.2 Zelgen Business Overview
7.3.3 Zelgen Hepatocellular Carcinoma Targeted Drug Major Product Offerings
7.3.4 Zelgen Hepatocellular Carcinoma Targeted Drug Revenue in Global Market (2017-2022)
7.3.5 Zelgen Key News
7.4 Cipla
7.4.1 Cipla Corporate Summary
7.4.2 Cipla Business Overview
7.4.3 Cipla Hepatocellular Carcinoma Targeted Drug Major Product Offerings
7.4.4 Cipla Hepatocellular Carcinoma Targeted Drug Revenue in Global Market (2017-2022)
7.4.5 Cipla Key News
7.5 Natco Pharma
7.5.1 Natco Pharma Corporate Summary
7.5.2 Natco Pharma Business Overview
7.5.3 Natco Pharma Hepatocellular Carcinoma Targeted Drug Major Product Offerings
7.5.4 Natco Pharma Hepatocellular Carcinoma Targeted Drug Revenue in Global Market (2017-2022)
7.5.5 Natco Pharma Key News
7.6 BEACON Pharma
7.6.1 BEACON Pharma Corporate Summary
7.6.2 BEACON Pharma Business Overview
7.6.3 BEACON Pharma Hepatocellular Carcinoma Targeted Drug Major Product Offerings
7.6.4 BEACON Pharma Hepatocellular Carcinoma Targeted Drug Revenue in Global Market (2017-2022)
7.6.5 BEACON Pharma Key News
7.7 Jiangxi Shanxiang
7.7.1 Jiangxi Shanxiang Corporate Summary
7.7.2 Jiangxi Shanxiang Business Overview
7.7.3 Jiangxi Shanxiang Hepatocellular Carcinoma Targeted Drug Major Product Offerings
7.7.4 Jiangxi Shanxiang Hepatocellular Carcinoma Targeted Drug Revenue in Global Market (2017-2022)
7.7.5 Jiangxi Shanxiang Key News
7.8 Yao Pharma
7.8.1 Yao Pharma Corporate Summary
7.8.2 Yao Pharma Business Overview
7.8.3 Yao Pharma Hepatocellular Carcinoma Targeted Drug Major Product Offerings
7.8.4 Yao Pharma Hepatocellular Carcinoma Targeted Drug Revenue in Global Market (2017-2022)
7.8.5 Yao Pharma Key News
7.9 CSPC
7.9.1 CSPC Corporate Summary
7.9.2 CSPC Business Overview
7.9.3 CSPC Hepatocellular Carcinoma Targeted Drug Major Product Offerings
7.9.4 CSPC Hepatocellular Carcinoma Targeted Drug Revenue in Global Market (2017-2022)
7.9.5 CSPC Key News
7.10 CHIATAI Tianqing
7.10.1 CHIATAI Tianqing Corporate Summary
7.10.2 CHIATAI Tianqing Business Overview
7.10.3 CHIATAI Tianqing Hepatocellular Carcinoma Targeted Drug Major Product Offerings
7.10.4 CHIATAI Tianqing Hepatocellular Carcinoma Targeted Drug Revenue in Global Market (2017-2022)
7.10.5 CHIATAI Tianqing Key News
7.11 Simcere
7.11.1 Simcere Corporate Summary
7.11.2 Simcere Business Overview
7.11.3 Simcere Hepatocellular Carcinoma Targeted Drug Major Product Offerings
7.11.4 Simcere Hepatocellular Carcinoma Targeted Drug Revenue in Global Market (2017-2022)
7.11.5 Simcere Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Hepatocellular Carcinoma Targeted Drug Market Opportunities & Trends in Global Market
Table 2. Hepatocellular Carcinoma Targeted Drug Market Drivers in Global Market
Table 3. Hepatocellular Carcinoma Targeted Drug Market Restraints in Global Market
Table 4. Key Players of Hepatocellular Carcinoma Targeted Drug in Global Market
Table 5. Top Hepatocellular Carcinoma Targeted Drug Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Hepatocellular Carcinoma Targeted Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Hepatocellular Carcinoma Targeted Drug Revenue Share by Companies, 2017-2022
Table 8. Global Companies Hepatocellular Carcinoma Targeted Drug Product Type
Table 9. List of Global Tier 1 Hepatocellular Carcinoma Targeted Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hepatocellular Carcinoma Targeted Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type - Global Hepatocellular Carcinoma Targeted Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Hepatocellular Carcinoma Targeted Drug Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Hepatocellular Carcinoma Targeted Drug Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application - Global Hepatocellular Carcinoma Targeted Drug Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Hepatocellular Carcinoma Targeted Drug Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Hepatocellular Carcinoma Targeted Drug Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region - Global Hepatocellular Carcinoma Targeted Drug Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Hepatocellular Carcinoma Targeted Drug Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Hepatocellular Carcinoma Targeted Drug Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Hepatocellular Carcinoma Targeted Drug Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Hepatocellular Carcinoma Targeted Drug Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Hepatocellular Carcinoma Targeted Drug Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Hepatocellular Carcinoma Targeted Drug Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Hepatocellular Carcinoma Targeted Drug Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Hepatocellular Carcinoma Targeted Drug Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Hepatocellular Carcinoma Targeted Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Hepatocellular Carcinoma Targeted Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Hepatocellular Carcinoma Targeted Drug Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Hepatocellular Carcinoma Targeted Drug Revenue, (US$, Mn), 2023-2028
Table 30. Bayer Corporate Summary
Table 31. Bayer Hepatocellular Carcinoma Targeted Drug Product Offerings
Table 32. Bayer Hepatocellular Carcinoma Targeted Drug Revenue (US$, Mn), (2017-2022)
Table 33. Eisai Corporate Summary
Table 34. Eisai Hepatocellular Carcinoma Targeted Drug Product Offerings
Table 35. Eisai Hepatocellular Carcinoma Targeted Drug Revenue (US$, Mn), (2017-2022)
Table 36. Zelgen Corporate Summary
Table 37. Zelgen Hepatocellular Carcinoma Targeted Drug Product Offerings
Table 38. Zelgen Hepatocellular Carcinoma Targeted Drug Revenue (US$, Mn), (2017-2022)
Table 39. Cipla Corporate Summary
Table 40. Cipla Hepatocellular Carcinoma Targeted Drug Product Offerings
Table 41. Cipla Hepatocellular Carcinoma Targeted Drug Revenue (US$, Mn), (2017-2022)
Table 42. Natco Pharma Corporate Summary
Table 43. Natco Pharma Hepatocellular Carcinoma Targeted Drug Product Offerings
Table 44. Natco Pharma Hepatocellular Carcinoma Targeted Drug Revenue (US$, Mn), (2017-2022)
Table 45. BEACON Pharma Corporate Summary
Table 46. BEACON Pharma Hepatocellular Carcinoma Targeted Drug Product Offerings
Table 47. BEACON Pharma Hepatocellular Carcinoma Targeted Drug Revenue (US$, Mn), (2017-2022)
Table 48. Jiangxi Shanxiang Corporate Summary
Table 49. Jiangxi Shanxiang Hepatocellular Carcinoma Targeted Drug Product Offerings
Table 50. Jiangxi Shanxiang Hepatocellular Carcinoma Targeted Drug Revenue (US$, Mn), (2017-2022)
Table 51. Yao Pharma Corporate Summary
Table 52. Yao Pharma Hepatocellular Carcinoma Targeted Drug Product Offerings
Table 53. Yao Pharma Hepatocellular Carcinoma Targeted Drug Revenue (US$, Mn), (2017-2022)
Table 54. CSPC Corporate Summary
Table 55. CSPC Hepatocellular Carcinoma Targeted Drug Product Offerings
Table 56. CSPC Hepatocellular Carcinoma Targeted Drug Revenue (US$, Mn), (2017-2022)
Table 57. CHIATAI Tianqing Corporate Summary
Table 58. CHIATAI Tianqing Hepatocellular Carcinoma Targeted Drug Product Offerings
Table 59. CHIATAI Tianqing Hepatocellular Carcinoma Targeted Drug Revenue (US$, Mn), (2017-2022)
Table 60. Simcere Corporate Summary
Table 61. Simcere Hepatocellular Carcinoma Targeted Drug Product Offerings
Table 62. Simcere Hepatocellular Carcinoma Targeted Drug Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Hepatocellular Carcinoma Targeted Drug Segment by Type in 2021
Figure 2. Hepatocellular Carcinoma Targeted Drug Segment by Application in 2021
Figure 3. Global Hepatocellular Carcinoma Targeted Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Hepatocellular Carcinoma Targeted Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Hepatocellular Carcinoma Targeted Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hepatocellular Carcinoma Targeted Drug Revenue in 2021
Figure 8. By Type - Global Hepatocellular Carcinoma Targeted Drug Revenue Market Share, 2017-2028
Figure 9. By Application - Global Hepatocellular Carcinoma Targeted Drug Revenue Market Share, 2017-2028
Figure 10. By Region - Global Hepatocellular Carcinoma Targeted Drug Revenue Market Share, 2017-2028
Figure 11. By Country - North America Hepatocellular Carcinoma Targeted Drug Revenue Market Share, 2017-2028
Figure 12. US Hepatocellular Carcinoma Targeted Drug Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Hepatocellular Carcinoma Targeted Drug Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Hepatocellular Carcinoma Targeted Drug Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Hepatocellular Carcinoma Targeted Drug Revenue Market Share, 2017-2028
Figure 16. Germany Hepatocellular Carcinoma Targeted Drug Revenue, (US$, Mn), 2017-2028
Figure 17. France Hepatocellular Carcinoma Targeted Drug Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Hepatocellular Carcinoma Targeted Drug Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Hepatocellular Carcinoma Targeted Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Hepatocellular Carcinoma Targeted Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Hepatocellular Carcinoma Targeted Drug Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Hepatocellular Carcinoma Targeted Drug Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Hepatocellular Carcinoma Targeted Drug Revenue Market Share, 2017-2028
Figure 24. China Hepatocellular Carcinoma Targeted Drug Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Hepatocellular Carcinoma Targeted Drug Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Hepatocellular Carcinoma Targeted Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Hepatocellular Carcinoma Targeted Drug Revenue, (US$, Mn), 2017-2028
Figure 28. India Hepatocellular Carcinoma Targeted Drug Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Hepatocellular Carcinoma Targeted Drug Revenue Market Share, 2017-2028
Figure 30. Brazil Hepatocellular Carcinoma Targeted Drug Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Hepatocellular Carcinoma Targeted Drug Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Hepatocellular Carcinoma Targeted Drug Revenue Market Share, 2017-2028
Figure 33. Turkey Hepatocellular Carcinoma Targeted Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Hepatocellular Carcinoma Targeted Drug Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Hepatocellular Carcinoma Targeted Drug Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Hepatocellular Carcinoma Targeted Drug Revenue, (US$, Mn), 2017-2028
Figure 37. Bayer Hepatocellular Carcinoma Targeted Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Eisai Hepatocellular Carcinoma Targeted Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Zelgen Hepatocellular Carcinoma Targeted Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Cipla Hepatocellular Carcinoma Targeted Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Natco Pharma Hepatocellular Carcinoma Targeted Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. BEACON Pharma Hepatocellular Carcinoma Targeted Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Jiangxi Shanxiang Hepatocellular Carcinoma Targeted Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Yao Pharma Hepatocellular Carcinoma Targeted Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. CSPC Hepatocellular Carcinoma Targeted Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. CHIATAI Tianqing Hepatocellular Carcinoma Targeted Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Simcere Hepatocellular Carcinoma Targeted Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE